HSBC downgraded Illumina (ILMN) to Hold from Buy with a $100 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Sell Rating Issued for Illumina Amid Competitive Threats from Roche’s NGS Platform
- Illumina’s Resilient Market Position Amid Emerging Competition: A Buy Recommendation by Puneet Souda
- Illumina’s Competitive Edge: Overcoming Challenges and Retaining Market Leadership
- Illumina weakness ‘overdone,’ says Wolfe Research
- Roche SBX announcement creates more uncertainty for Illumina, says RBC